Analysis and Commentary STEVEN GROSSMAN 9/18/20 Analysis and Commentary STEVEN GROSSMAN 9/18/20 Public Trust in the US FDA Read More Analysis and Commentary STEVEN GROSSMAN 9/3/20 Analysis and Commentary STEVEN GROSSMAN 9/3/20 Understanding Tom Frieden's Proposed HDO Read More Analysis and Commentary STEVEN GROSSMAN 8/14/20 Analysis and Commentary STEVEN GROSSMAN 8/14/20 "Somehow the CR Will Pass", But When? Read More Analysis and Commentary STEVEN GROSSMAN 8/7/20 Analysis and Commentary STEVEN GROSSMAN 8/7/20 CDER Priorities: During the Pandemic and for 2021 Read More Analysis and Commentary STEVEN GROSSMAN 8/1/20 Analysis and Commentary STEVEN GROSSMAN 8/1/20 About the Alliance for a Stronger FDA Read More Analysis and Commentary STEVEN GROSSMAN 7/18/20 Analysis and Commentary STEVEN GROSSMAN 7/18/20 Why No Movement in the Senate? Read More Analysis and Commentary STEVEN GROSSMAN 7/10/20 Analysis and Commentary STEVEN GROSSMAN 7/10/20 CBER Director on COVID-19 and Vaccine Development Read More Analysis and Commentary STEVEN GROSSMAN 6/26/20 Analysis and Commentary STEVEN GROSSMAN 6/26/20 FDA Is Its People … and They Need Our Support (Redux) Read More Analysis and Commentary STEVEN GROSSMAN 6/19/20 Analysis and Commentary STEVEN GROSSMAN 6/19/20 How Well Is This Year's Appropriation Process Working? Read More Analysis and Commentary STEVEN GROSSMAN 6/12/20 Analysis and Commentary STEVEN GROSSMAN 6/12/20 "I Believe in FDA Exceptionalism and You Should Too" Read More Analysis and Commentary STEVEN GROSSMAN 6/5/20 Analysis and Commentary STEVEN GROSSMAN 6/5/20 Pandemic Actions Taken ... and Lessons Learned Read More Analysis and Commentary STEVEN GROSSMAN 5/15/20 Analysis and Commentary STEVEN GROSSMAN 5/15/20 How H.R. 6800 Might Impact the FDA Read More Analysis and Commentary STEVEN GROSSMAN 5/8/20 Analysis and Commentary STEVEN GROSSMAN 5/8/20 The Frieden Health Defense Funding Proposition Read More Analysis and Commentary STEVEN GROSSMAN 5/1/20 Analysis and Commentary STEVEN GROSSMAN 5/1/20 No Need for a Crystal Ball in Some Scenarios Read More Analysis and Commentary STEVEN GROSSMAN 4/24/20 Analysis and Commentary STEVEN GROSSMAN 4/24/20 How Can Congress Agree to Appropriations for FY 21? Read More Analysis and Commentary STEVEN GROSSMAN 4/17/20 Analysis and Commentary STEVEN GROSSMAN 4/17/20 The COVID-19 Pandemic and Maintenance of a Continued Safe Food Supply Read More Analysis and Commentary STEVEN GROSSMAN 4/3/20 Analysis and Commentary STEVEN GROSSMAN 4/3/20 Advocating for a Responsibility-based "Ask" Read More Analysis and Commentary STEVEN GROSSMAN 3/27/20 Analysis and Commentary STEVEN GROSSMAN 3/27/20 Coronavirus, Pandemic Preparedness, and Beyond Read More Analysis and Commentary STEVEN GROSSMAN 3/19/20 Analysis and Commentary STEVEN GROSSMAN 3/19/20 Alliance for a Stronger FDA -- FY 21 “Ask” and Explanation Read More Analysis and Commentary STEVEN GROSSMAN 3/13/20 Analysis and Commentary STEVEN GROSSMAN 3/13/20 "Cures," Coronavirus, NDD, and Other Issues for FY 21 Read More Newer Posts Older Posts
Analysis and Commentary STEVEN GROSSMAN 9/18/20 Analysis and Commentary STEVEN GROSSMAN 9/18/20 Public Trust in the US FDA Read More
Analysis and Commentary STEVEN GROSSMAN 9/3/20 Analysis and Commentary STEVEN GROSSMAN 9/3/20 Understanding Tom Frieden's Proposed HDO Read More
Analysis and Commentary STEVEN GROSSMAN 8/14/20 Analysis and Commentary STEVEN GROSSMAN 8/14/20 "Somehow the CR Will Pass", But When? Read More
Analysis and Commentary STEVEN GROSSMAN 8/7/20 Analysis and Commentary STEVEN GROSSMAN 8/7/20 CDER Priorities: During the Pandemic and for 2021 Read More
Analysis and Commentary STEVEN GROSSMAN 8/1/20 Analysis and Commentary STEVEN GROSSMAN 8/1/20 About the Alliance for a Stronger FDA Read More
Analysis and Commentary STEVEN GROSSMAN 7/18/20 Analysis and Commentary STEVEN GROSSMAN 7/18/20 Why No Movement in the Senate? Read More
Analysis and Commentary STEVEN GROSSMAN 7/10/20 Analysis and Commentary STEVEN GROSSMAN 7/10/20 CBER Director on COVID-19 and Vaccine Development Read More
Analysis and Commentary STEVEN GROSSMAN 6/26/20 Analysis and Commentary STEVEN GROSSMAN 6/26/20 FDA Is Its People … and They Need Our Support (Redux) Read More
Analysis and Commentary STEVEN GROSSMAN 6/19/20 Analysis and Commentary STEVEN GROSSMAN 6/19/20 How Well Is This Year's Appropriation Process Working? Read More
Analysis and Commentary STEVEN GROSSMAN 6/12/20 Analysis and Commentary STEVEN GROSSMAN 6/12/20 "I Believe in FDA Exceptionalism and You Should Too" Read More
Analysis and Commentary STEVEN GROSSMAN 6/5/20 Analysis and Commentary STEVEN GROSSMAN 6/5/20 Pandemic Actions Taken ... and Lessons Learned Read More
Analysis and Commentary STEVEN GROSSMAN 5/15/20 Analysis and Commentary STEVEN GROSSMAN 5/15/20 How H.R. 6800 Might Impact the FDA Read More
Analysis and Commentary STEVEN GROSSMAN 5/8/20 Analysis and Commentary STEVEN GROSSMAN 5/8/20 The Frieden Health Defense Funding Proposition Read More
Analysis and Commentary STEVEN GROSSMAN 5/1/20 Analysis and Commentary STEVEN GROSSMAN 5/1/20 No Need for a Crystal Ball in Some Scenarios Read More
Analysis and Commentary STEVEN GROSSMAN 4/24/20 Analysis and Commentary STEVEN GROSSMAN 4/24/20 How Can Congress Agree to Appropriations for FY 21? Read More
Analysis and Commentary STEVEN GROSSMAN 4/17/20 Analysis and Commentary STEVEN GROSSMAN 4/17/20 The COVID-19 Pandemic and Maintenance of a Continued Safe Food Supply Read More
Analysis and Commentary STEVEN GROSSMAN 4/3/20 Analysis and Commentary STEVEN GROSSMAN 4/3/20 Advocating for a Responsibility-based "Ask" Read More
Analysis and Commentary STEVEN GROSSMAN 3/27/20 Analysis and Commentary STEVEN GROSSMAN 3/27/20 Coronavirus, Pandemic Preparedness, and Beyond Read More
Analysis and Commentary STEVEN GROSSMAN 3/19/20 Analysis and Commentary STEVEN GROSSMAN 3/19/20 Alliance for a Stronger FDA -- FY 21 “Ask” and Explanation Read More
Analysis and Commentary STEVEN GROSSMAN 3/13/20 Analysis and Commentary STEVEN GROSSMAN 3/13/20 "Cures," Coronavirus, NDD, and Other Issues for FY 21 Read More
